Clin. Immunol..2020 Jul;218:108542. S1521-6616(20)30439-3. doi: 10.1016/j.clim.2020.108542.Epub 2020-07-12.
腸内マイクロバイオームトランスファー、COVID-19誘発性高炎症の新規治療戦略？In reply to, 'COVID-19.免疫学および治療オプション」、フェルゼンシュタイン、ハーバート・マクナマラら、２０２０'
Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, 'COVID-19: Immunology and treatment options', Felsenstein, Herbert McNamara et al. 2020'.
- James R McIlroy
- Benjamin H Mullish
- Simon D Goldenberg
- Gianluca Ianiro
- Julian R Marchesi
PMID: 32663514 PMCID: PMC7354373. DOI: 10.1016/j.clim.2020.108542.
抄録
抄録はありません
